Related Experiment Video
Updated: Feb 8, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.5K
Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
Marcos I Restrepo1,2, Oriol Sibila3, Antonio Anzueto1,4
1South Texas Veterans Health Care System, San Antonio, TX, USA.
Tuberculosis and Respiratory Diseases
|July 3, 2018
Summary
Pneumonia significantly increases risks for patients with chronic obstructive pulmonary disease (COPD). Inhaled corticosteroid use in COPD patients raises pneumonia risk, highlighting the importance of vaccinations for prevention.
Area of Science:
- Pulmonology
- Infectious Diseases
- Epidemiology
Background:
- Chronic obstructive pulmonary disease (COPD) is a common comorbidity linked to higher illness and death rates.
- Pneumonia represents the most frequent infectious disease diagnosis.
- COPD patients face increased risks for pneumonia, impacting overall health outcomes.
Purpose of the Study:
- To assess the impact of pneumonia in individuals diagnosed with COPD.
- To examine the epidemiology and contributing factors of pneumonia in COPD patients.
- To review clinical features of COPD that predispose to infections like pneumonia.
Main Methods:
- Literature review focusing on COPD and pneumonia.
- Analysis of epidemiological data and risk factors.
- Evaluation of clinical characteristics and treatment impacts.
Main Results:
- Evidence indicates an increased risk of pneumonia in COPD patients using inhaled corticosteroids over the past decade.
- Specific COPD clinical characteristics may facilitate pneumonia development.
- Vaccination strategies are crucial for pneumonia prevention in this population.
Conclusions:
- Pneumonia poses a significant threat to COPD patients, increasing morbidity and mortality.
- Inhaled corticosteroid therapy is associated with a higher incidence of pneumonia in COPD.
- Influenza and pneumococcal vaccinations are vital for preventing pneumonia in COPD management.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.8K